Macumira – Advanced Non‑Invasive Therapy for Dry AMD

Supporting Your Eyes with Gentle, Needle‑Free Treatment

​

Dry Age‑related Macular Degeneration (dry AMD) affects central vision and can make everyday tasks like reading and recognizing faces harder. While there’s currently no cure for dry AMD, Macumira offers an innovative, needle‑free therapy designed to support macular health and visual function using low‑pulse energy delivered through a comfortable headset. Each session lasts just 32 minutes and requires no needles, no injections, and no drugs.

​

Macumira is intended to be a safe, relaxing, and non‑invasive option for patients seeking care beyond supplements and lifestyle management.

​

How Macumira Therapy Works

​

Macumira’s patented technology uses targeted low‑pulse electrical energy that is safely delivered through a headset to the surface of the eyes. This low‑pulse stimulation is designed to influence cellular processes in the retina and may:

• Support macular function in eyes affected by dry AMD

• Encourage healthy cellular activity without tissue damage

• Provide a gentle, comfortable experience with no recovery time

This approach is part of a broader category of non‑invasive ocular therapies being explored in eye research, including light‑based and microcurrent stimulation techniques.

​

What to Expect During Your Visit

​

• Comfort First: You’ll wear a soft, custom‑fitting headset — no needles or injections involved.

• Relaxing Treatment: Each session lasts about 32 minutes in a calm, clinical environment.

• Needle‑Free and Drug‑Free: Most patients find the therapy pleasant and comfortable.

• No Downtime: You can resume your normal day immediately after your session.

Macumira is designed to fit into your life with minimal disruption and maximum comfort.

​

Who Is Macumira For?

​

Macumira is specifically intended for adults diagnosed with dry AMD, including:

• Patients early in the course of dry AMD who want proactive support

• Individuals experiencing changes in vision due to macular degeneration

• Those who prefer non‑invasive, needle‑free options

• Patients seeking to complement lifestyle and clinical care plans

Because every case of dry AMD is unique, your eye care provider will assess whether Macumira is suitable for you.

​

Scientific Evidence and Research

​

Macumira’s approach reflects a growing area of research into non‑invasive energy‑based therapies for dry AMD:

​

• Microcurrent Electrical Stimulation: A clinical trial found improved visual acuity and contrast sensitivity in dry AMD patients treated with transpalpebral microcurrent electrical stimulation compared to sham control groups, indicating potential functional benefits.

• Photobiomodulation Research: Low‑level light therapy and other energy‑based interventions are under investigation as non‑invasive methods to support retinal cell function. Some studies suggest safety and short‑term benefits in visual outcomes, though the overall evidence base is still developing and larger trials are needed.

​

Photobiomodulation in Ophthalmology: Reviews highlight that non‑invasive therapies like photobiomodulation may have promising applications in dry AMD and other ocular conditions, though continued research is required.

Note: While promising, these approaches — including Macumira — are emerging, and research continues to evolve. Always discuss the latest clinical evidence with your eye care professional.

​

Patient FAQ

​

Q: Is Macumira safe?
A: Yes. Macumira is a non‑invasive, needle‑free treatment. Clinical research on related energy‑based therapies indicates good safety and tolerability. However, your clinician will evaluate your individual eye health before treatment.

​

Q: How long is each session?
A: Each treatment session takes about 32 minutes.

​

Q: Does it hurt?
A: No — most patients report a gentle sensation or slight tingling but no pain.

​

Q: How many sessions will I need?
A: Treatment plans are personalized based on your condition and goals. Your specialist will recommend the best schedule for you.

​

Q: Will this cure my dry AMD?
A: There is currently no cure for dry AMD. Macumira is designed to support visual function and macular health, not cure the disease. Outcomes vary among individuals.

​

Q: How soon might I notice improvement?
A: Some patients report better visual comfort and improved contrast within a few sessions, though individual results vary.

​

​